Famciclovir | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Famciclovir
Health Canada Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Famciclovir

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

23 API Suppliers, 11 USDMF, 5 JDMF, 7 EU WC, 13 KDMF, 7 NDC API, 13 Listed Suppliers, $ API Reference Price

23 API Suppliers
11 USDMF
5 JDMF
7 EU WC
13 KDMF
7 NDC API
13 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

12 Drugs in Development

12 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

121 FDF Dossiers, 27 FDA Orange Book, 45 Europe, 9 Canada, 26 Australia, 6 South Africa, 8 Listed Dossiers

121 FDF Dossiers
27 FDA Orange Book
45 Europe
9 Canada
26 Australia
6 South Africa
8 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 125MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 2 SPI Pharma, 2 Seqens, 10 DKSH, 4 Faran Shimi Pharmaceutical, 5 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 6 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 Pramukh Pharmachem, 1 ACG Worldwide, 5 Actylis, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 28 BASF, 1 Clariant, 10 Corel Pharma Chem, 7 DFE Pharma, 1 Finar, 12 Gangwal Chemicals, 5 Ideal Cures Pvt Ltd, 2 Ingredion Pharma Solutions, 36 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 15 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 3 Novo Excipients, 5 Pharmatrans-Sanaq, 4 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 15 Roquette, 12 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

65 Fillers, Diluents & Binders, 48 Coating Systems & Additives, 39 Disintegrants & Superdisintegrants, 27 Direct Compression, 27 Solubilizers, 26 Thickeners and Stabilizers, 26 Controlled & Modified Release, 26 Granulation, 22 Lubricants & Glidants, 15 Topical, 15 Film Formers & Plasticizers, 12 Parenteral, 11 Co-Processed Excipients, 9 Chewable & Orodispersible Aids, 7 Emulsifying Agents, 5 Rheology Modifiers, 5 Empty Capsules, 5 API Stability Enhancers, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 3 Surfactant & Foaming Agents

65 Fillers, Diluents & Binders
48 Coating Systems & Additives
39 Disintegrants & Superdisintegrants
27 Direct Compression
27 Solubilizers
26 Thickeners and Stabilizers
26 Controlled & Modified Release
26 Granulation
22 Lubricants & Glidants
15 Topical
15 Film Formers & Plasticizers
12 Parenteral
11 Co-Processed Excipients
9 Chewable & Orodispersible Aids
7 Emulsifying Agents
5 Rheology Modifiers
5 Empty Capsules
5 API Stability Enhancers
4 Vegetarian Capsules
4 Taste Masking
4 Coloring Agents
3 Surfactant & Foaming Agents

DIGITAL CONTENT

5 NEWS #PharmaBuzz

5 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 62 Finished Drug Prices

1 US Medicaid Prescriptions
62 Finished Drug Prices

MARKET PLACE

3 APIs

3 APIs

PATENTS & EXCLUSIVITIES

13 Health Canada Patents

13 Health Canada Patents

REF. STANDARDS & IMPURITIES

7 USP, 7 Others

7 USP
7 Others

$ API Ref.Price (USD/KG) : 786 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

13 All

01 7Gowling Strathy & Henderson

02 6Blank

filter Patent Reset all filters

13 All

01 31262899

02 32011238

03 32086756

04 22173505

05 22176392

filter Product Reset all filters

13 All

01 7Famciclovir

02 6Blank

filter Dosage Reset all filters

13 All

01 7Tablet

02 6Blank

filter Exp Date Reset all filters

13 All

01 32006-11-14

02 32010-03-01

03 32011-07-03

04 22014-10-04

05 22014-11-11

Product Main Page

01

Gowling Strathy & Henderson

Famciclovir

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Famciclovir

Brand Name : FAMVIR

Patent Number : 2173505

Filing Date : 1994-10-04

Strength per Unit : 125 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowling Strathy & Henderson

Famciclovir

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2086756

Filing Date : 1991-07-03

Strength per Unit : 125 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowling Strathy & Henderson

Famciclovir

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2176392

Filing Date : 1994-11-11

Strength per Unit : 125 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

Gowling Strathy & Henderson

Famciclovir

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Famciclovir

Brand Name : FAMVIR

Patent Number : 2173505

Filing Date : 1994-10-04

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-10-04

Date Granted : 2005-03-29

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Gowling Strathy & Henderson

Famciclovir

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2086756

Filing Date : 1991-07-03

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

Gowling Strathy & Henderson

Famciclovir

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2176392

Filing Date : 1994-11-11

Strength per Unit : 250 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2014-11-11

Date Granted : 2005-11-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

Gowling Strathy & Henderson

Famciclovir

BioAsia

Not Confirmed

Gowling Strathy & Henderson

Canada

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Famciclovir

Brand Name : FAMVIR

Patent Number : 2086756

Filing Date : 1991-07-03

Strength per Unit : 500 mg

Dosage Form : Tablet

Human Or VET : Human

Route of Administration : Oral

Patent Expiration Date : 2011-07-03

Date Granted : 2003-04-08

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

Famciclovir

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2006-11-14

Date Granted :

Famciclovir

Brand Name :

Patent Number : 1262899

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2006-11-14

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

09

Famciclovir

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2006-11-14

Date Granted :

Famciclovir

Brand Name :

Patent Number : 1262899

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2006-11-14

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

10

Famciclovir

BioAsia

Not Confirmed

Country

BioAsia

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2006-11-14

Date Granted :

Famciclovir

Brand Name :

Patent Number : 1262899

Filing Date :

Strength per Unit :

Dosage Form :

Human Or VET :

Route of Administration :

Patent Expiration Date : 2006-11-14

Date Granted :

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!